Polygenic profiles define aspects of clinical heterogeneity in attention deficit hyperactivity disorder
Sonja LaBianca(Mental Health Services), Andrew J. Schork(University of Copenhagen), Søren Dalsgaard(Lundbeck Foundation), Ole Mors(Aarhus University), Preben Bo Mortensen(Aarhus University), Isabell Brikell(Aarhus University), Daniel H. Geschwind(University of California, Los Angeles), Marianne Giørtz Pedersen(Aarhus University), Anders D. Børglum(Aarhus University), Rebecca L. Walker(Broad Institute), Dorte Helenius(Mental Health Services), Merete Nordentoft(University of Copenhagen), Robert Loughnan(J. Craig Venter Institute), Joel Mefford(University of California, Los Angeles), Thomas Werge(Cardiff University), Esben Agerbo(Aarhus University), Jesper R. Gådin(Mental Health Services), Andrew Dahl(University of Chicago), Terry L. Jernigan(Cognitive Research (United States)), Noah Zaitlen(University of California, Los Angeles), Morten Dybdahl Krebs(Sankt Hans Hospital), Morteza Vaez(Amager Hospital), Vivek Appadurai(Mental Health Services), David M. Hougaard(Statens Serum Institut), Kenneth S. Kendler(Virginia Commonwealth University), Andrés Ingason(deCODE Genetics (Iceland)), Clare E. Palmer(NHS Digital)
Cited by 26
Related Papers
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
The Basics of Brain Development
|Neuropsychology Review|2010|2k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k